{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:14:33Z","timestamp":1769271273364,"version":"3.49.0"},"reference-count":43,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"unspecified","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"shanghai ninth people's hospital affiliated to jiaotong University school of medicine"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,11,10]]},"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Women with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization (IVF) protocols are typically characterised by an increased number of oocytes retrieved. The oocytes are often of poor quality, leading to lower pregnancy rates, higher miscarriage rates and an increased risk of developing ovarian hyperstimulation syndrome (OHSS). Since our previous preliminary study showed that a novel progestin-primed ovarian stimulation (PPOS) protocol blocked the luteinising hormone (LH) surge during IVF and achieved a higher pregnancy rate with a lower incidence of OHSS, we designed a prospective randomised controlled trial to compare the efficacy and safety of this PPOS protocol with the flexible gonadotropin-releasing hormone (GnRH) antagonist protocol in patients with PCOS who are undergoing IVF procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>Patients with PCOS will be randomised to one of two controlled ovarian stimulation regimens\u2014GnRH antagonist or PPOS\u2014using a computer-generated random number. A freeze-all strategy using embryo vitrification techniques and frozen embryo transfer will be performed in both groups. The primary outcome is the live-birth rate per transfer. Secondary outcomes include the incidence of premature LH surges, the duration and total dose of human menopausal gonadotropin stimulation, the number of oocytes retrieved, the incidence of moderate or severe OHSS, the number of embryos available for transfer, implantation rates, clinical pregnancy rates, pregnancy loss rates, ectopic pregnancy rates, pregnancy and neonatal complications, and congenital anomalies. The necessary sample size for this trial was estimated as 392 participants, with 196 participants in each group. Intention-to-treat analysis was used in processing our experimental data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study was approved by the Institutional Review Board of the hospital (2016-133-T82). The trial will be conducted according to the principles of the World Medical Association\u2019s Declaration of Helsinki and in accordance with Good Clinical Practice standards. The findings of this trial will be published in a peer-reviewed journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ChiCTRIPR16009580.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-038153","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T16:41:15Z","timestamp":1606927275000},"page":"e038153","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of a progestin-primed ovarian stimulation protocol with a flexible GnRH antagonist protocol in patients with polycystic ovary syndrome who are participating in an IVF programme: study protocol for a randomised controlled trial"],"prefix":"10.1136","volume":"10","author":[{"given":"Ningling","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Assisted Reproduction, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Assisted Reproduction, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Assisted Reproduction, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Assisted Reproduction, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Assisted Reproduction, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5640-5010","authenticated-orcid":false,"given":"Yun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Assisted Reproduction, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Kuang","sequence":"additional","affiliation":[{"name":"Department of Assisted Reproduction, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,12,2]]},"reference":[{"key":"2025121410250991000_10.12.e038153.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61345-2"},{"key":"2025121410250991000_10.12.e038153.2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep399"},{"key":"2025121410250991000_10.12.e038153.3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2025121410250991000_10.12.e038153.4","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmp008"},{"key":"2025121410250991000_10.12.e038153.5","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmi036"},{"key":"2025121410250991000_10.12.e038153.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-007-0462-x"},{"key":"2025121410250991000_10.12.e038153.7","doi-asserted-by":"crossref","first-page":"072","DOI":"10.1055\/s-2007-992927","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"26","author":"Boomsma","year":"2008","journal-title":"Semin Reprod Med"},{"key":"2025121410250991000_10.12.e038153.8","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmq032"},{"key":"2025121410250991000_10.12.e038153.9","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0b013e31815e85fc"},{"key":"2025121410250991000_10.12.e038153.10","doi-asserted-by":"crossref","first-page":"053","DOI":"10.1055\/s-2007-992925","article-title":"Implications of polycystic ovary syndrome on oocyte development","volume":"26","author":"Dumesic","year":"2008","journal-title":"Semin Reprod Med"},{"key":"2025121410250991000_10.12.e038153.11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.fertnstert.2018.06.005","article-title":"Forty years of IVF","volume":"110","author":"Niederberger","year":"2018","journal-title":"Fertil Steril"},{"key":"2025121410250991000_10.12.e038153.12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"Gnrh antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Hum Reprod Update"},{"key":"2025121410250991000_10.12.e038153.13","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"5","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121410250991000_10.12.e038153.14","first-page":"84","article-title":"Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study","volume":"50","author":"Bah\u00e7eci","year":"2005","journal-title":"J Reprod Med"},{"key":"2025121410250991000_10.12.e038153.15","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep436"},{"key":"2025121410250991000_10.12.e038153.16","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/humrep\/dey044","article-title":"Live birth rates in the first complete IVF cycle among 20 687 women using a freeze-all strategy","volume":"33","author":"Zhu","year":"2018","journal-title":"Hum Reprod"},{"key":"2025121410250991000_10.12.e038153.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705334"},{"key":"2025121410250991000_10.12.e038153.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1513873"},{"key":"2025121410250991000_10.12.e038153.19","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002939","article-title":"Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: a double-blind randomized crossover clinical trial","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine"},{"key":"2025121410250991000_10.12.e038153.20","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-15-154","article-title":"Live birth after fresh embryo transfer vs elective embryo cryopreservation\/frozen embryo transfer in women with polycystic ovary syndrome undergoing IVF (FreFro-PCOS): study protocol for a multicenter, prospective, randomized controlled clinical trial","volume":"15","author":"Shi","year":"2014","journal-title":"Trials"},{"key":"2025121410250991000_10.12.e038153.21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1329"},{"key":"2025121410250991000_10.12.e038153.22","doi-asserted-by":"crossref","unstructured":"Lainas T , Zorzovilis J , Petsas G , et al . In a flexible antagonist protocol, earlier, criteria-based initiation of GnRH antagonist is associated with increased pregnancy rates in IVF. Hum Reprod 2005, 20(9):2426-2433.","DOI":"10.1093\/humrep\/dei106"},{"key":"2025121410250991000_10.12.e038153.23","doi-asserted-by":"publisher","DOI":"10.1007\/BF01133388"},{"key":"2025121410250991000_10.12.e038153.24","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-018-2850-x","article-title":"Gonadotropin-Releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial","volume":"19","author":"Wang","year":"2018","journal-title":"Trials"},{"key":"2025121410250991000_10.12.e038153.25","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)60042-9"},{"key":"2025121410250991000_10.12.e038153.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)55188-7"},{"key":"2025121410250991000_10.12.e038153.27","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.fertnstert.2016.08.048","article-title":"Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline","volume":"106","year":"2016","journal-title":"Fertil Steril"},{"key":"2025121410250991000_10.12.e038153.28","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.bpobgyn.2004.06.001","article-title":"The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome","volume":"18","author":"van der Spuy","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2025121410250991000_10.12.e038153.29","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1042958"},{"key":"2025121410250991000_10.12.e038153.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1993.tb15170.x"},{"key":"2025121410250991000_10.12.e038153.31","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmn015"},{"key":"2025121410250991000_10.12.e038153.32","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deg266"},{"key":"2025121410250991000_10.12.e038153.33","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.12.5925"},{"key":"2025121410250991000_10.12.e038153.34","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/3.2.95"},{"key":"2025121410250991000_10.12.e038153.35","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.12.2471"},{"key":"2025121410250991000_10.12.e038153.36","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-43310"},{"key":"2025121410250991000_10.12.e038153.37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6655.1024"},{"key":"2025121410250991000_10.12.e038153.38","doi-asserted-by":"publisher","DOI":"10.1210\/endo-92-5-1496"},{"key":"2025121410250991000_10.12.e038153.39","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-58-2-378"},{"key":"2025121410250991000_10.12.e038153.40","first-page":"74","article-title":"The effects of progesterone on oocyte maturation and embryo development","volume":"7","author":"Salehnia","year":"2013","journal-title":"Int J Fertil Steril"},{"key":"2025121410250991000_10.12.e038153.41","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.2.290"},{"key":"2025121410250991000_10.12.e038153.42","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1350335"},{"key":"2025121410250991000_10.12.e038153.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.08.002"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-038153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:25:22Z","timestamp":1765736722000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-038153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,2]]},"published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1136\/bmjopen-2020-038153"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-038153","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]}}}